MetLife Inc
NYSE: MET · FINANCIAL SERVICES · INSURANCE - LIFE
Updated 2026-04-29
MetLife Inc (MET) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for MET.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
MET historical valuation range
Where current P/E sits in MET's own 5Y range.
MET intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
MET valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 16.50x
P/S Ratio — History
Current: 0.66x
Is MET overvalued in 2026?
MetLife Inc (MET) currently trades at $78.96 per share with a market capitalization of $50,664,583,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 63/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 16.5x, above its 5-year median of 15.5x. The PEG ratio of 0.41 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, MET is currently trading more expensive than 72% of the last 5Y on P/E. This places it in the 72th percentile of its historical range, a reasonable but unremarkable position.
A standard DCF model does not produce reliable output for MET under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: MET trades at a fair valuation on our framework, with a Smart Value Score of 63/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is MET overvalued in 2026?
Based on a Smart Value Score of 63/100, MET is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is MET's fair value?
Standard DCF is unreliable for MET due to its current profitability profile. Revenue-based approaches such as EV/Sales or historical P/S percentile are more informative for this stock.
What P/E ratio does MET trade at?
MET trades at a P/E of 16.5x on trailing twelve-month earnings, compared to its 5-year median of 15.5x.
Is MET a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 63/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does MET's valuation compare to its history?
On P/E, MET currently sits in the 72th percentile of its own 5Y range. That is above its long-run median relative to where it has traded over the period.
What is MET's Smart Value Score?
MET's Smart Value Score is 63/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.